An important role in assessing the
important role in assessing the recovery function of the transplanted kidney and diagnosing posttransplant complications [4, 5] . At the same time, the absence of adverse reactions to the radiopharmaceutical (RPh), a low radiation dose, and a high reproducibility of results are essential.
As a rule, glomerulotropic RPh (   99m   Tc-DTPA, or   99m Tc-Pentatech, a Russian-manufactured analogue filtered by renal glomeruli) or tubulotropic RPhs ( 123 I-hippurate and 99m Tc-MAG3 secreted in the proximal tubules) are used to evaluate the renal graft function. None of these drugs has any essential advantages over the others, but in repeated studies it is recommended to use one and the same RPh [6, 7] . A wide experience has been gained in the world practice in using the radionuclide method in kidney transplantation, which provides important information to solve such problems as acute tubular necrosis (ATN), acute rejection crisis (ARC), vascular complications, urinary tract damage, and urinary leakage, and also to perform long-term monitoring of renal graft function while the patient being on immunosuppression therapy [8, 9] . Nevertheless, we have found no published studies in the available literature that would have investigated the relationship between the graft functional abnormalities detected by angionephroscintigraphy in the posttransplant period and the pre-existing HLA-sensitization of a recipient; and this encouraged us to publish our study.
The objective was to assess and monitor the allograft function after cadaveric kidney transplantation by using the results of angionephroscintigraphy with Tc-Pentatech and to investigate the relationship of the obtained data with pre-existing HLA sensitization level.
Material and methods
The results of the radionuclide assay performed in 55 patients (33 women, 22 men) in the early postoperative period in time from 5 days to 3 months after cadaveric kidney allotransplantation (CKAT) were analyzed. function. In each group, the recipients were allocated into subgroups (a, b, c) depending on the presence and level of pre-existing anti-HLA antibodies ( Fig. 1) .
Fig.1. Recipient allocation in groups
The anti-HLA antibody levels in recipient blood were detected just prior to transplantation by multiplexed assay on the Luminex platform using
LabScreen kits (One Lambda, USA). Serum reactivity was assessed by the fluorescence signal; the result was qualified as negative sensitization at mean fluorescence intensity (MFI) not exceeding 500 a.u., as a moderate HLA sensitization level at MFI values of 500-3000 a.u., and as a high HLA sensitization level at MFI over 3000 a.u. [10] .
Dynamic angionephroscintigraphy was performed on Infinia II gamma camera (GE, US) using glomerulotropic radiopharmaceutical 
Study results
According to angionephroscintigraphy results, the majority of patients At the same time, two patients without pre-existing anti-HLA antibodies and with a satisfactory blood supply demonstrated significant impairments of filtration and excretion, and the renogram above the kidney region was different from the parenchymal type. In one case, the assay performed on day 26 after CKAT yielded the obturational type curve over the region of the transplanted kidney. There was an uncompromised perfusion (PI = 154.5), but a significantly decreased filtration and an abruptly decreased excretory function were observed. In the other case with slightly reduced perfusion (PI = 190), the curve over the kidney region was of isostenuric type, abruptly decreased filtration and excretion were noted. The more difficult for diagnosis and making the treatment plan were the patients with delayed graft function (Group 2). Those patients without anti-HLA antibodies in blood (MFI lower 500 a.u.) (subgroup 2a; n=12
[63.2%] of 19 recipients) were examined in the period from day 6 to 60 after CKAT. In most cases, they were studied 2-3 times. The first study showed a parenchymal type of the curves in 6 (50%) patients, other patients with a severely impaired function had isostenuric or obturational renogram types.
At the same time, in all the patients, filtration and excretion were reduced to a greater extent than in Group 1. At repeated studies, all of them showed an insignificant improvement of all graft function components. The exception was a patient in whom all the parameters had deteriorated by day 24, the renogram acquired an obturational type with an abruptly decreased filtration, which suggested the ATN development (Fig. 4) . The outcome renograms were of obturational type in 3 recipients, of isostenuric type in 2 others having either preserved or slightly reduced perfusion, abruptly impaired filtration and excretion, which was also typical for ischemic injury of the graft or ATN. In those patients, the graft function had partially restored by day 18-30, which was accompanied by an increased RPh accumulation in kidney, an increased EI parameter; the renograms acquired a parenchymal type, but all parameters reflecting perfusion, filtration, and excretion remained significantly reduced (Fig. 5) .
A female patient from 2a subgroup was examined on day 17 after CKAT, the renogram kept an afunctional type with the perfusion being satisfactory, which suggested a severe tubular dysfunction that slightly improved on day 29; an incomplete recovery of kidney function was observed on day 43. At the same time, the renogram remained isostenuric, however, the quantitative parameters of GFR and AI improved (Fig. 6 ). In the subgroup of HLA-sensitized patients with MFI ranging from 500-3000 a.u. who showed a delayed graft function recovery (subgroup 2b), 2 patients were examined. In one of them, the scintigraphy was performed on days 6 and 10: the curves in both cases were of the parenchymal type with abruptly reduced perfusion that could serve as a sign of ARC (Fig. 7) . In the most severe, highly HLA-sensitized patients with MFI over Fig. 8 and 9 ). (Fig. 10 and 11) . 3. In the patients with delayed graft function, the scintigraphy data suggested a marked functional impairment, and the higher was the pretransplant HLA sensitization level of the patient, the more significant was the reduction of filtration and excretion due to tubular dysfunction. Partial recovery of the function in response to pharmacological therapy was observed after 3-4 weeks, mainly due to the improvement of GFR and excretion.
4. In the patients with a delayed allograft function and a high level of pre-existing anti-HLA antibodies (MFI > 3000 a.u.), an abrupt reduction in perfusion typical for ARC, and an impaired filtration were noted initially, the latter gradually improving (within 30 days) as the perfusion recovered.
In the same group of patients, an impaired excretion was frequent indicating concomitant severe ischemic injury of the kidneys or ATN.
